- Home
- TLX vs ACHR Comparison
TLX vs ACHR Comparison
Compare TLX & ACHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- ACHR
- Stock Information
- Founded
- TLX 2015
- ACHR 2018
- Country
- TLX Australia
- ACHR United States
- Employees
- TLX N/A
- ACHR N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- ACHR Aerospace
- Sector
- TLX Health Care
- ACHR Industrials
- Exchange
- TLX Nasdaq
- ACHR Nasdaq
- Market Cap
- TLX 5.7B
- ACHR 6.4B
- IPO Year
- TLX N/A
- ACHR N/A
- Fundamental
- Price
- TLX $15.57
- ACHR $10.80
- Analyst Decision
- TLX Strong Buy
- ACHR Strong Buy
- Analyst Count
- TLX 3
- ACHR 8
- Target Price
- TLX $22.33
- ACHR $13.13
- AVG Volume (30 Days)
- TLX 50.1K
- ACHR 42.6M
- Earning Date
- TLX 01-01-0001
- ACHR 08-07-2025
- Dividend Yield
- TLX N/A
- ACHR N/A
- EPS Growth
- TLX 798.14
- ACHR N/A
- EPS
- TLX 0.09
- ACHR N/A
- Revenue
- TLX $484,687,790.00
- ACHR N/A
- Revenue This Year
- TLX N/A
- ACHR N/A
- Revenue Next Year
- TLX N/A
- ACHR N/A
- P/E Ratio
- TLX $168.47
- ACHR N/A
- Revenue Growth
- TLX 55.85
- ACHR N/A
- 52 Week Low
- TLX $13.61
- ACHR $2.82
- 52 Week High
- TLX $30.36
- ACHR $13.92
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- ACHR 54.37
- Support Level
- TLX N/A
- ACHR $9.76
- Resistance Level
- TLX N/A
- ACHR $11.30
- Average True Range (ATR)
- TLX 0.00
- ACHR 0.60
- MACD
- TLX 0.00
- ACHR 0.03
- Stochastic Oscillator
- TLX 0.00
- ACHR 67.53
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.